Skip to content

The effect of clary sage(salvia sclarea) in diabetic foot patients diagnosed with type 2 DM

The effect of clary sage(salvia sclarea) inhalation in diabetic foot patients diagnosed with type 2 DM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009722
Enrollment
75
Registered
2024-08-23
Start date
2023-06-21
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The control group was administered 100% almond oil, and experimental groups 1 and 2 were administered 5% clary sage essential oil and 5% linalyl acetate oil, respectively. The oils of the exper

Sponsors

Koera University Guro Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with type 2 diabetes aged 19 years or older Patients who have not been diagnosed with an olfactory disorder (sensorineural olfactory disorder, conductive olfactory disorder) Patients who can communicate with others without orientation difficulties. Patients who do not have an allergic reaction to the fragrance oils used in this study. Patients who are not receiving medication, hormones, or essential oil treatment due to mental illness

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients suspected of having systemic infection Patients with mental illness, drug or alcohol addiction, or those who cannot understand the purpose and methods of this clinical trial Patients who have experienced an allergic reaction to the fragrance oils used in this study Others (patients for whom the researcher judged it difficult to conduct this clinical trial)

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;depression-VAS;stress-VAS;anxiety-VAS

Secondary

MeasureTime frame
pain-VAS

Countries

Korea, Republic of

Contacts

Public ContactJi Won Son

Koera University Guro Hospital

sonjiwon@korea.ac.kr+82-2-3290-4698

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026